J.P. Marvel Investment Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.15M | Buy |
59,416
+1,771
| +3% | +$170K | 0.73% | 34 |
|
|
2025
Q4 | $5.54M | Buy |
57,645
+1,000
| +2% | +$97.1K | 0.77% | 31 |
|
|
2025
Q3 | $5.39M | Buy |
56,645
+24
| +0% | +$2.21K | 0.78% | 32 |
|
|
2025
Q2 | $4.94M | Sell |
56,621
-435
| -0.8% | -$36.9K | 0.79% | 32 |
|
|
2025
Q1 | $5.13M | Hold |
57,056
| – | – | 0.89% | 32 |
|
|
2024
Q4 | $4.56M | Sell |
57,056
-250
| -0.4% | -$21.6K | 0.75% | 35 |
|
|
2024
Q3 | $5.16M | Sell |
57,306
-690
| -1% | -$58K | 0.84% | 31 |
|
|
2024
Q2 | $4.56M | Hold |
57,996
| – | – | 0.75% | 33 |
|
|
2024
Q1 | $5.05M | Buy |
57,996
+460
| +0.8% | +$39.3K | 0.87% | 33 |
|
|
2023
Q4 | $4.74M | Hold |
57,536
| – | – | 0.94% | 29 |
|
|
2023
Q3 | $4.51M | Buy |
57,536
+300
| +0.5% | +$25.1K | 0.97% | 30 |
|
|
2023
Q2 | $5.04M | Buy |
57,236
+150
| +0.3% | +$12.9K | 1.05% | 30 |
|
|
2023
Q1 | $4.6M | Hold |
57,086
| – | – | 1.04% | 31 |
|
|
2022
Q4 | $4.44M | Hold |
57,086
| – | – | 1.04% | 33 |
|
|
2022
Q3 | $4.61M | Sell |
57,086
-12
| -0% | -$1.08K | 1.17% | 31 |
|
|
2022
Q2 | $5.13M | Hold |
57,098
| – | – | 1.23% | 31 |
|
|
2022
Q1 | $6.33M | Hold |
57,098
| – | – | 1.29% | 30 |
|
|
2021
Q4 | $5.91M | Sell |
57,098
-160
| -0.3% | -$18.5K | 1.15% | 30 |
|
|
2021
Q3 | $7.18M | Buy |
57,258
+30
| +0.1% | +$3.88K | 2.16% | 19 |
|
|
2021
Q2 | $7.1M | Hold |
57,228
| – | – | 1.51% | 27 |
|
|
2021
Q1 | $6.76M | Sell |
57,228
-20
| -0% | -$2.34K | 1.6% | 27 |
|
|
2020
Q4 | $6.71M | Hold |
57,248
| – | – | 1.73% | 26 |
|
|
2020
Q3 | $5.95M | Hold |
57,248
| – | – | 1.71% | 25 |
|
|
2020
Q2 | $5.25M | Sell |
57,248
-680
| -1% | -$65.2K | 1.66% | 26 |
|
|
2020
Q1 | $5.22M | Hold |
57,928
| – | – | 1.98% | 23 |
|
|
2019
Q4 | $6.57M | Buy |
57,928
+18
| +0% | +$1.98K | 1.9% | 20 |
|
|
2019
Q3 | $6.29M | Buy |
+57,910
| New | +$6.04M | 2.01% | 17 |
|
|
2019
Q1 | $5.27M | Hold |
57,910
| – | – | 1.71% | 24 |
|
|
2018
Q4 | $5.27M | Buy |
+57,910
| New | +$5.41M | 1.9% | 21 |
|
|
2018
Q2 | $4.99M | Sell |
58,240
-60
| -0.1% | -$5.01K | 1.53% | 24 |
|
|
2018
Q1 | $4.68M | Sell |
58,300
-4,000
| -6% | -$330K | 1.44% | 28 |
|
|
2017
Q4 | $5.03M | Sell |
62,300
-242
| -0.4% | -$19.4K | 1.53% | 26 |
|
|
2017
Q3 | $4.86M | Sell |
62,542
-518
| -0.8% | -$43K | 1.55% | 25 |
|
|
2017
Q2 | $5.6M | Sell |
63,060
-140
| -0.2% | -$11.8K | 1.85% | 21 |
|
|
2017
Q1 | $5.09M | Sell |
63,200
-1,711
| -3% | -$134K | 1.68% | 21 |
|
|
2016
Q4 | $4.62M | Hold |
64,911
| – | – | 1.58% | 26 |
|
|
2016
Q3 | $5.61M | Sell |
64,911
-2,170
| -3% | -$189K | 1.99% | 21 |
|
|
2016
Q2 | $5.82M | Sell |
67,081
-282
| -0.4% | -$22.8K | 2.04% | 18 |
|
|
2016
Q1 | $5.05M | Sell |
67,363
-189
| -0.3% | -$14.2K | 1.82% | 22 |
|
|
2015
Q4 | $5.2M | Buy |
+67,552
| New | +$5.09M | 1.81% | 21 |
|
|
2015
Q2 | $5.02M | Hold |
67,772
| – | – | 1.69% | 24 |
|
|
2015
Q1 | $5.29M | Hold |
67,772
| – | – | 1.8% | 21 |
|
|
2014
Q4 | $4.89M | Hold |
67,772
| – | – | 1.7% | 21 |
|
|
2014
Q3 | $4.2M | Sell |
67,772
-189
| -0.3% | -$12K | 1.52% | 27 |
|
|
2014
Q2 | $4.33M | Hold |
67,961
| – | – | 1.47% | 28 |
|
|
2014
Q1 | $4.18M | Sell |
67,961
-1,970
| -3% | -$115K | 1.47% | 27 |
|
|
2013
Q4 | $4.01M | Buy |
69,931
+1,130
| +2% | +$64.1K | 1.44% | 30 |
|
|
2013
Q3 | $3.66M | Hold |
68,801
| – | – | 1.42% | 29 |
|
|
2013
Q2 | $3.54M | Buy |
+68,801
| New | +$3.4M | 1.47% | 31 |
|
Other funds holding MDT
VCM
VPM
J.P. Marvel Investment Advisors's MDT Position: Q1 2026 in Review
J.P. Marvel Investment Advisors increased its Medtronic (MDT) stake by 3.1% in Q1 2026, buying an estimated $170K and bringing the position to 59,416 shares worth $5.15M. The position accounts for 0.73% of the portfolio, ranked #34.
J.P. Marvel Investment Advisors first reported a position in MDT in Q2 2013 and has held it in 49 quarters since. The position peaked at $7.18M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- J.P. Marvel Investment Advisors held 59,416 shares of Medtronic worth $5.15M as of Q1 2026.
- J.P. Marvel Investment Advisors bought 1,771 Medtronic shares in Q1 2026, an estimated $170K.
- Medtronic made up 0.73% of J.P. Marvel Investment Advisors's portfolio in Q1 2026, its #34 holding.
- J.P. Marvel Investment Advisors first reported a position in Medtronic in Q2 2013 and has held it in 49 quarters since.
- J.P. Marvel Investment Advisors's Medtronic position peaked at $7.18M in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on J.P. Marvel Investment Advisors's 13F filing for Q1 2026, filed 6 May 2026.